1. Cell death-based treatment of neuroblastoma
   Kadri Valter et al, 2018, Cell Death & Disease CrossRef
2. MYCN in Neuroblastoma: “Old Wine into New Wineskins”
   Maria Braoudaki et al, 2021, Diseases CrossRef
3. Nothing but NET: A review of norepinephrine transporter expression and efficacy of 131I‐mIBG therapy
   Keri A. Streby et al, 2015, Pediatric Blood & Cancer CrossRef
4. Protein Expression Analysis in Uterine Cervical Cancer for Potential Targets in Treatment
   Sugela Blancas et al, 2019, Pathology & Oncology Research CrossRef
5. Targeting metabolic dependencies in pediatric cancer
   Sameer H. Issaq et al, 2020, Current Opinion in Pediatrics CrossRef
6. Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma
   Janith A. Seneviratne et al, 2023, International Journal of Cancer CrossRef
7. Energy Metabolism and Metabolic Targeting of Neuroblastoma
   Sepideh Aminzadeh-Gohari et al, 2019, Neuroblastoma CrossRef
8. Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy
   Antonio Gil-Gomez et al, 2018, Revista Española de Enfermedades Digestivas CrossRef
9. Synthesis and Characterization of Lipophilic Salts of Metformin to Improve Its Repurposing for Cancer Therapy
   Hiwa K. Saeed et al, 2021, ACS Omega CrossRef
10. Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
    Luis Enrique Munoz et al, 2021, Journal for ImmunoTherapy of Cancer CrossRef
11. NEAT1 Negatively Regulates Cell Proliferation and Migration of Neuroblastoma Cells by miR-183-5p/FOXP1 Via the ERK/AKT Pathway
    Weikang Pan et al, 2020, Cell Transplantation CrossRef
12. Context-dependent prediction of protein complexes by SiComPre
    Simone Rizzetto et al, 2018, npj Systems Biology and Applications CrossRef
13. Targeting of heme oxygenase‐1 as a novel immune regulator of neuroblastoma
    Stefan Fest et al, 2016, International Journal of Cancer CrossRef